.jpg?format=webp&quality=80&width=3840)
Obesity is a significant risk factor for severe disease in COVID‐19, with increased hospitalization, intensive care unit admission, and mortality. This increased impact of COVID‐19 in people with obesity (PWO) is likely driven partly by the well‐described obesity‐induced immune dysregulation. Obesity has also been associated with impaired immune memory, including weakened responses to hepatitis B, tetanus, rabies, and influenza vaccination. It was recently reported that PWOs with COVID‐19 had reduced IgG antibody titers with defective neutralizing capabilities. However, it remains unknown whether PWO generates durable T-cell immunity to SARS‐CoV‐2.
Like
Save
Share